Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(33%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_1
1
11%
Ph phase_2
3
33%
Ph not_applicable
3
33%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
3(42.9%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(4)

Detailed Status

Completed4
Recruiting3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (14.3%)
Phase 23 (42.9%)
N/A3 (42.9%)

Trials by Status

not_yet_recruiting222%
recruiting333%
completed444%

Recent Activity

3 active trials
Showing 5 of 9
recruitingphase_1

Evaluation of the Safety of LipiodolⓇ Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment

NCT06611007
not_yet_recruitingnot_applicable

Embolization of Ovarian Vein and Pelvic Venous Reservoir for Treatment of Secondary Pelvic Congestion Syndrome

NCT07472504
recruitingnot_applicable

Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200

NCT06930677
not_yet_recruitingnot_applicable

Evaluation of the Non-inferiority of Resorbable Gelatin Embolization Compared to Embolization Combined With Endometrial Aspiration for the Management of Hemorrhagic Uterine Vascular Abnormalities Following Premature Termination of Pregnancy

NCT07206342
recruiting

Treatment of Desmoid Fibromatosis With Arterial Embolization

NCT06945887
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT06611007Phase 1

Evaluation of the Safety of LipiodolⓇ Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment

Recruiting
NCT07472504Not Applicable

Embolization of Ovarian Vein and Pelvic Venous Reservoir for Treatment of Secondary Pelvic Congestion Syndrome

Not Yet Recruiting
NCT06930677Not Applicable

Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200

Recruiting
NCT07206342Not Applicable

Evaluation of the Non-inferiority of Resorbable Gelatin Embolization Compared to Embolization Combined With Endometrial Aspiration for the Management of Hemorrhagic Uterine Vascular Abnormalities Following Premature Termination of Pregnancy

Not Yet Recruiting
NCT06945887

Treatment of Desmoid Fibromatosis With Arterial Embolization

Recruiting
NCT06595264

Vein of Galen Aneurysm

Completed
NCT03472586Phase 2

Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver

Completed
NCT00335829Phase 2

Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Completed
NCT00028626Phase 2

Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9